Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Amy McGranahan

    TitleResearch Coordinator II
    SchoolKeck School of Medicine of USC
    DepartmentSurgery
    AddressGNH 1937 Hospital Place
    Off Campus
    Los Angeles California 90031
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lee-Sherick AB, Eisenman KM, Sather S, McGranahan A, Armistead PM, McGary CS, Hunsucker SA, Schlegel J, Martinson H, Cannon C, Keating AK, Earp HS, Liang X, DeRyckere D, Graham DK. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 2016 Dec 01; 35(48):6270. PMID: 27593932.
        View in: PubMed
      2. Knez VM, Carstens BJ, Swisshelm KL, McGranahan A, Liang X. Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia. Am J Clin Pathol. 2015 Aug; 144(2):305-14. PMID: 26185316.
        View in: PubMed
      3. Linger RM, Lee-Sherick AB, DeRyckere D, Cohen RA, Jacobsen KM, McGranahan A, Brandão LN, Winges A, Sawczyn KK, Liang X, Keating AK, Tan AC, Earp HS, Graham DK. Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. Blood. 2013 Aug 29; 122(9):1599-609. PMID: 23861246.
        View in: PubMed
      4. Lee-Sherick AB, Eisenman KM, Sather S, McGranahan A, Armistead PM, McGary CS, Hunsucker SA, Schlegel J, Martinson H, Cannon C, Keating AK, Earp HS, Liang X, DeRyckere D, Graham DK. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 2013 Nov 14; 32(46):5359-68. PMID: 23474756.
        View in: PubMed
      5. Brandao LN, Winges A, Christoph S, Sather S, Migdall-Wilson J, Schlegel J, McGranahan A, Gao D, Liang X, Deryckere D, Graham DK. Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia. Blood Cancer J. 2013 Jan 25; 3:e101. PMID: 23353780.
        View in: PubMed
      6. Liang X, Jones A, Giller RH, Swisshelm K, McGavran L, Meltesen L, Carstens B, McGranahan A, Albano EA. Primary high-grade B-cell lymphoma of the breast with concurrent IGH-BCL2 and MYC-IGL translocations in an adolescent patient. Pediatr Dev Pathol. 2011 Sep-Oct; 14(5):402-6. PMID: 21491965.
        View in: PubMed
      7. Liang X, Greffe B, Cook B, Giller R, Graham DK, McGranahan A, Wang M. Gray zone lymphomas in pediatric patients. Pediatr Dev Pathol. 2011 Jan-Feb; 14(1):57-63. PMID: 20331368.
        View in: PubMed